Thus, Lu and coworkers have provided evidence that high Nanog and Oct4 expression in primary pancreatic cancer had a negative prognostic impact, and Nanog and Oct4 knockdown in CSCs isolated from prostate cancer cell lines resulted in a reduction of proliferation, invasion, chemoresistance and tumorigenesis [161]. The gene discussed is POU5F1; the disease is pancreatic neoplasm.